Raleigh, NC, March 18, 2010 --(PR.com
)-- Tom Sturgis, president of ICTS (Integrated Clinical Trial Services, LLC) (www.icts.us), has announced that the company’s article, “Improve Site Performance,” was published in the March 2010 issue of Future Pharmaceuticals. An accompanying podcast interview was featured on the trade publication’s Web site. The article, written by Gregg Sweet, vice president of strategy and development at ICTS, discusses how to reduce time and cost in study enrollments. In the podcast, Sweet describes how to avoid delays in enrollment and best steps to take to improve the enrollment process. To read the article or listen to the podcast, visit www.futurepharmaus.com.
“We are pleased that Gregg’s article was published in Future Pharmaceuticals,” said Sturgis. “ICTS works to reduce cost and time in study enrollment for our clients, and the article and podcast provide important information for those managing clinical trials.”
- ICTS works to create unique, time-sensitive strategies to meet pharmaceutical clients’ clinical trial enrollment challenges.
ICTS (Integrated Clinical Trial Services, LLC) is a creative, innovative and flexible partner for strategic clinical trials support. The full-service firm utilizes more than 300 contract employees internationally to provide medical communications, patient enrollment feasibility, recruitment strategy, consulting, market research and protocol review, project management, concept design and production, media placement, community resource support, compliance and retention, and more. The ICTS management team has completed more than 300 successful patient recruitment programs and has more than 60 years of active involvement in patient accrual. A successful trial depends on the quality of the underlying recruitment plan, and ICTS is dedicated to constructing the right solution based upon each client’s protocol and needs. For more information please call (919) 388-3964 or visit the Web site at www.icts.us.
MMI Public Relations